Retinitis Pigmentosa Management

Retinitis Pigmentosa (RP) is a group of inherited diseases that damage the light-sensitive rods and cones located in the retina, the back part of our eyes. Rods, which provide side (peripheral) and night vision are affected more than the cones which provide color and clear central vision.

Signs of RP usually appear during early adolescence. The first sign is often night blindness followed by a slow loss of side vision. Over the years, the disease may cause further loss of side vision. RP patients usually see as if they are in a tunnel.

MicroCurrent Stimulation (MCS) is an enhanced adaptation of a FDA approved therapy used to promote the healing of wounds and transplanted tissues as well as to treat pain. The treatment of patients with RP entails the periodic administration of very precise amounts of tightly controlled electrical current through electrodes applied to the skin at specific areas around the eye. The electrical current is used to stimulate the retina as well as the diseased macula in order to restore sight. The procedure is safe, non-invasive and painless and no side effects or adverse reactions have been observed. MCS has been used successfully for many years in treating various other diseases where it was shown to increase blood flow and improve the energy level of the cells in the area being treated.